dihexa clinical trial — Peptide Therapy Online dihexa peptide sciences dihexa stability
Description
TB-500 is currently available through licensed compounding pharmacies in the US under clinician supervision
A randomised controlled trial published in Clinical Infectious Diseases demonstrated that Thymosin Alpha-1 treatment in severe COVID-19 patients reduced 28-day mortality by 30% compared to standard care alone.17 While this was acute disease, not long COVID, it confirms the biological plausibility of the immune mechanism
J.ZhouX.et al (2008)
Be sure it has a well-fitting top that closes tightly
